Biohaven Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	273.07	229.96	99.13	248.4	204.88	76.06
Short-Term Investments	74.74	89.18	386.86	133.42	260.46	-
Cash & Short-Term Investments	347.82	319.14	485.99	381.82	465.34	76.06
Cash Growth	7.77%	-34.33%	27.28%	-17.95%	511.83%	-7.82%
Other Receivables	-	-	-	13.25	46.14	9.91
Total Trade Receivables	-	-	-	13.25	46.14	9.91
Other Current Assets	37.83	49.19	52.48	47.38	75.49	8.86
Total Current Assets	385.65	368.33	538.47	442.45	586.97	94.82
Net Property, Plant & Equipment	15.26	15.96	17.32	17.19	17.51	13.01
Other Intangible Assets	18.4	18.4	18.4	18.4	18.4	18.4
Goodwill	1.39	1.39	1.39	1.39	1.39	1.39
Other Long-Term Assets	45.71	47.36	39.53	33.79	37.51	14.44
Total Assets	466.41	451.45	615.11	513.21	661.78	142.06
Accounts Payable	10.42	11.64	18.03	15.58	10.7	4.78
Accrued Expenses	41.65	104.29	51.49	39.85	44.11	37.16
Other Current Liabilities	-	-	84.71	-	35.21	-
Total Current Liabilities	52.08	115.93	154.23	55.42	90.02	41.94
Long-Term Debt	241.91	238.9	-	-	-	-
Long-Term Leases	38.36	39.96	32.78	27.57	30.58	2.8
Other Long-Term Liabilities	4.56	4.58	4.66	2.25	2.41	2.64
Total Long-Term Liabilities	284.83	283.44	37.45	29.81	32.99	5.44
Total Liabilities	336.91	399.38	191.67	85.24	123.01	47.37
Common Stock	2,336	-	-	887.53	615.74	-
Additional Paid-in Capital	-	-	-	39.8	13.87	-
Accumulated Other Comprehensive Income	8.3	8.35	0.08	-0.07	0.28	-
Retained Earnings	-2,215	-2,085	-1,346	-499.29	-91.12	-
Total Common Shareholders' Equity	129.5	-2,076	-1,346	427.98	538.77	34.69
Minority Interest	-	-	-	-	-	60
Shareholders' Equity	129.5	-2,076	-1,346	427.98	538.77	94.69
Total Liabilities & Equity	466.41	451.45	615.11	513.21	661.78	142.06
Total Debt	280.28	278.86	32.78	27.57	30.58	2.8
Net Cash (Debt)	67.54	40.28	453.21	354.25	434.76	73.26
Net Cash Growth	67.69%	-91.11%	27.93%	-18.52%	493.45%	-11.21%
Net Cash Per Share	0.57	0.37	4.97	4.97	9.72	1.86
Book Value	129.5	-2,076	-1,346	427.98	538.77	34.69
Book Value Per Share	1.09	-19.29	-14.75	6.01	12.04	0.88
Tangible Book Value	109.71	-2,096	-1,365	408.19	518.98	14.9
Tangible Book Value Per Share	0.92	-19.47	-14.97	5.73	11.60	0.38

SEC Filings: 10-K · 10-Q